Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.

Get started from just $1/month


1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Total Analysts: 0

Company Profile

Rafael Holdings, Inc. owns interests in pre-clinical and clinical-stage pharmaceutical companies and commercial real estate assets. The Company is focused on the discovery of cancer and immune metabolism therapeutics. The Company operates through two segments: Pharmaceuticals and Real Estate. The Pharmaceuticals segment is comprised of preferred and common equity interests and the Warrant to purchase equity interests in Rafael Pharmaceuticals, a majority equity interest in LipoMedix, Barer, Levco, Farber and Rafael Medical Devices. The Real Estate segment consists of the Company’s real estate holdings associated with a public garage and a portion of an office building in Israel.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan